Structured treatment interruptions to control HIV-1 infection

Lancet

Volumn 355, Issue 9200, 2000, Pages 287-288

  Lori, F ^a,b   Maserati, R ^c   Foli, A ^a,b   Seminari, E ^c   Timpone, J ^d   Lisziewicz, J ^a,b  

^a Research Institute for Genetic and Human Therapy (RIGHT)   (Italy)

^b 3900 Reservoir Road NW ^*  (United States)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; HYDROXYUREA; PROTEINASE INHIBITOR; VIRUS RNA;

ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; REBOUND; SEROCONVERSION; TREATMENT PLANNING; VIRUS LOAD;

EID: 0034700847     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03515-1     Document Type: Article

References (4)

1. Finzi D., Blankson J., Siliciano J.D.et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 5:1999;512-517.
2. Jubault V., Burgard M., LeCorfec E., Costagliola D., Rouzioux C., Viard J.P. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy. AIDS. 12:1998;2358-2359.
3. de Jong M.D., de Boer R.J., de Wolf F.et al. Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment. AIDS. 11:1997;F79-84.
4. Lisziewicz J., Rosenberg E., Lieberman J.et al. Control of HIV despite the discontinuation of antiretroviral therapy. N Engl J Med. 340:1999;1683-1684.